Among many cytokines, irradiated B16 melanoma tumor cells expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) could arouse potent, durable, and specific anti-tumor immunity, activating both CD4+ and CD8+ cells. Here, CD8A is linked to melanoma.